Silica as an Excipient: Functions, Grades and Pharmaceutical Applications

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: What Is Silica Gel? How It Works, Types and Uses as a Desiccant and Adsorbent
  • Keywords: U.S. Silica
  • Published: 2026-11-20 13:47:46
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals

Toothpaste Grade Silica: Abrasive vs Thickening Silica, RDA Values and Specifications

Polysilicon vs Silica: From Quartz Sand to Solar-Grade Silicon
Mesoporous silica nanoparticles have poor powder rheology and poor flow properties, due to their low bulk density, small particle size, and high hygroscopicity, which make further processing and formulation, especially with direct compression, difficult [ 104 ]. This issue can be eliminated by granulating the carriers. Flowability and compactibility can also be boosted by granulation [ 86, 104 ]. During granulation, the desired degree of dispersity is attained by agglomeration of the particles, thereby creating a best possible flow characteristic. However, it is true that during granulation, the specific surface area and the pore volume of the carrier may decrease, also decreasing its adsorption capacity, which is a disadvantage from the facet of the API absorption [ 104, 105 ]. However, since this reduction is mostly negligible compared to the total specific surface area, a substantial improvement in its flow properties can considerably improve the overall performance [ 104, 105 ]. The critical parameters for the process are the following: the quantity of granulating liquid, the liquid addition rate, the mixing speed, the process time, and the temperature. Of course, the applied binder also plays an essential part in the process [ 105 ]. These parameters affect the granule size, specific surface area, bulk density, flow properties (Hausner-factor, Carr-index), crushing strength, compressibility, and compactibility [ 105 ].
Foundry Silica Sand: AFS Grain Fineness, Specifications and Uses
Silica Aerogel Insulation: Thermal Performance, Uses and Cost Comparison
Fused Silica Powder Supplier: Purity, Particle Size Options and Selection Tips

Silica Demand in 2026: Key Industries Driving Growth

What is silica (SiO₂)?

80. Ajit J. Nanoparticles in Drug Delivery. Prem. J. Sci. 2025;1:100048. doi: 10.70389/PJS.100048. [ DOI ] [ Google Scholar ]

What is the difference between fumed silica and precipitated silica?

silica supplier Turkey Targeted therapy, aiming, for instance, at antitumor treatments, can be divided into active and passive forms [ 72, 73 ]. Passive targeting is based on higher vascularity and higher vascular permeability of the tumor, as well as inflamed tissues, compared to physiological ones [ 73, 74 ]. Additionally, the lymphatic circulation of the tumor shows decreased efficiency [ 25 ], which led to easier accumulation of nanoparticles in the tumor or inflamed tissues [ 10, 27, 72, 74 ]. This passive accumulation is normally called "ELVIS" (Extravasation through Leaky Vasculature and later Inflammatory cell-mediated Sequestration) [ 72, 74 ]. From the facet of surface qualities, negatively charged nanoparticles accumulate less effectively inside cells, due to the negatively charged cell membrane, which slows down the cellular uptake, so, in this case, a neutral surface charge is more favorable [ 25 ]. In contrast, active targeting can be accomplished by functionalizing the outer surface of the silica carriers [ 10, 27, 72 ], where molecules are attached to the surface of the carriers that specifically bind to certain cell surface ligands and receptors, which are characteristic of tumor-, but not of healthy cells. This selective method provides more effective treatment and reduces the side impacts of cytotoxic APIs on healthy cells and tissues [ 10, 27 ]. The most recent findings on active targeting possibilities are summarized in Table 3. García-Fernández et al. prepared a mesoporous silica-based nanocarrier loaded with dexamethasone and capped with a particular protein to actively target the TNFR1 receptor, which is overexpressed in pro-inflammatory macrophages [ 72 ]. Since the carriers are preferably internalized by these macrophages, the cargo is released in a controlled manner, during enzymatic hydrolysis, thus preventing premature drug release, thanks to the gatekeepers. The targeting talent was tested in vitro with activated macrophages. On the other hand, the therapeutic efficiency was tested in vivo in mouse models. The researchers observed greater therapeutic impacts and fewer adverse side influences than in the case of free dexamethasone. To sum up, dexamethasone-loaded MSN has been effectively developed to actively target the lungs in acute lung injury (ALI), and this result may also be promising in other lung diseases (COPD, asthma) [ 72 ]. Teruel et al. presented a novel approach in oral inflammatory bowel sickness (IBD) therapy, using functionalized magnetic mesoporous silica microparticles [ 75 ].

What drives silica raw material prices?

copper clad laminate filler 5. Drug Release

Cite this article: Silica Raw Materials News. "Silica Stocks: Publicly Listed Silica and Quartz Companies to Know ." Published 2026-11-20 13:47:46. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.